Fortress Biotech Sees Upgrades Amid Investor Shifts by Lilu Anderson 20.06.2024 "Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."
Patterson Companies Reports Modest Q4 Growth Amid Challenges by Mark Eisenberg 19.06.2024 "Patterson Companies posts 1% Q4 internal sales growth despite cybersecurity hit, highlights strong pet and production animal markets for future."
Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding by Mark Eisenberg 19.02.2024 Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...